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Abstract
Anterior chamber depth (ACD) is a key anatomical risk factor for primary angle closure glaucoma (PACG). We conducted a
genome-wide association study (GWAS) on ACD to discover novel genes for PACG on a total of 5,308 population-based
individuals of Asian descent. Genome-wide significant association was observed at a sequence variant within ABCC5
(rs1401999; per-allele effect size =20.045 mm, P= 8.1761029). This locus was associated with an increase in risk of PACG in
a separate case-control study of 4,276 PACG cases and 18,801 controls (per-allele OR= 1.13 [95% CI: 1.06–1.22], P= 0.00046).
The association was strengthened when a sub-group of controls with open angles were included in the analysis (per-allele
OR= 1.30, P= 7.4561029; 3,458 cases vs. 3,831 controls). Our findings suggest that the increase in PACG risk could in part be
mediated by genetic sequence variants influencing anterior chamber dimensions.
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Introduction
Primary angle closure glaucoma (PACG) remains a major cause
of irreversible blindness, particularly in Asian countries such as
China [1], Mongolia [2], Singapore [3], and India [4] with up to
80% of the estimated 15 million people afflicted with PACG
resident in Asia [5]. We recently conducted a genome-wide
association study (GWAS) on PACG with 3,771 PACG cases and
18,551 controls, and identified 3 strongly associated genetic
variants: rs11024102 in PLEKHA7, rs3753841 in COL11A1 and
rs1015213 located between PCMTD1 and ST18 on Chromosome
8q [6]. As these 3 sequence variants only explained ,2 percent of
PACG risk, we looked into other methodologies besides the
GWAS based approaches to identify more genes that underlie
PACG susceptibility. The clinical heterogeneity of PACG suggests
that disease-related endophenotypes/quantitative traits may help
elucidate true disease genes. Quantitative phenotypes allow
individuals to be viewed along the continuum of risk, and may
provide additional information which could complement dichot-
omous measures of affection status [7], [8]. Such an approach has
been used in the study of genetic variants controlling lipid traits
and susceptibility to coronary artery disease [7], [8].
Smaller anterior segment dimensions are a hallmark of PACG,
with shallower anterior chamber depth (ACD), the cardinal feature
associated with increased susceptibility to PACG [9], [10]. Eyes with
an ACD of less than 2.80 mm were more inclined to have angle
closure when compared to eyes with an ACD of at least 3 mm (odds
ratio (OR), 42.5; 95% confidence interval (CI), 27.4–66.2) [11].
There is also a greater likelihood of developing glaucomatous optic
neuropathy in persons with the shallowest anterior chambers [12].
ACD, an easily and precisely quantified measure by ocular
imaging techniques, is a normally distributed quantitative trait
within the general population. It displays high heritability with a
coefficient as high as 0.90 [13], [14], and can be considered an
endophenotype for PACG.
To identify genetic variants that significantly influence ACD, and
to determine if such genes (if any) affects PACG risk, we conducted a
two-staged study, first a GWAS on a total of 4,484 population-based
individuals of Indian and Malay ethnicity from Singapore, and
Chinese from Beijing, China. Secondly, the identified QTLs for
ACD were assessed for association in PACG case cohorts.
Results
Identification of a QTL for ACD
After sample and genotyping QC, a total of 1752 (Singapore
Malay Eye Study, SiMES), 1860 (Singapore Indian Eye Study,
SINDI), and 872 (Beijing Eye Study, BES) individuals with com-
plete data for ACD measurements, age and gender were available
for GWA analysis. We measured the association between ACD
and individual SNP genotypes using linear regression, modeling
for a trend-per-copy effect on the minor allele. Additional ad-
justments were made for age, gender, and the significant axes of
genetic stratification. We noted a significant excess of small P-
values at the extreme tail of the quantile-quantile distribution
(Figure S1) accompanied by a background of minimal genomic
inflation, thus indicating that there could be genuine associations
between SNP genotypes and ACD. Highly suggestive evidence of
association (P=1.9261027) was observed at a sequence variant
within ABCC5 (rs1401999) on Chromosome 3 (Figure S2). We
were able to replicate of this observation in a further 824
population-based samples of Chinese descent from Beijing, China
(P=0.011) using Sanger sequencing, leading to genome-wide
significant association with ACD upon meta-analysis of all 5,308
population-based samples (b=20.045 mm ACD per-copy of the
minor allele (C allele), P=8.1761029; Table 1). Furthermore,
attesting to the robustness of our findings, we observed a similar
magnitude of association when using left eye ACD measurements
of SiMES and SINDI cohorts (b=20.051, P= 8.1561024 and
b=20.045, P= 8.1161025 respectively), where left eye ACD data
were also available.
Additionally, as both ACD and axial length are distance
measurements on the axial direction of the eye globe, previously
described to share genetic factors to a certain degree [15], we also
assessed the effect of ABCC5 rs1401999 on axial length. We found
the association between rs1401999 and axial length to be much
weaker compared to that observed with ACD (P-meta = 0.000615,
Table S1).
Association between ABCC5 rs1401999 and PACG
For the second analysis, we examined if this variant was
associated with PACG, and proceeded to conduct analysis of 1,854
PACG cases and 9,608 controls from 5 cohorts (Table S2), all
genotyped with Illumina SNP-arrays, and a further 2,422 cases
and up to 9,193 controls from 7 independent collections
genotyped using the Sequenom MassArray or Taqman platforms.
As there was significant heterogeneity for the effect of ABCC5
rs1401999 and PACG risk between the 12 sample collections
(Pheterogeneity = 0.0047, I
2-index = 60.6%; Figure 1 and Table 2),
we looked for sources of possible heterogeneity within the sample
collections [16], the most obvious of which are the use of
clean, open angle controls in some collections (see ‘Selection of
controls without angle closure’ in methods), and un-ascertained
population-based controls in others. This could be important in
the context of this study as the prevalence of at-risk population
with inherent angle closure is as high as 10% in Asian populations
[3], [17]. Overall, we noted modest evidence of association (per-
allele odds ratio = 1.13, 95% confidence interval = 1.06–1.22;
P=0.00046) between the minor allele (C allele) of rs1401999
and PACG when all 12 case-control collections were considered,
and this association was augmented when we only included pre-
selected sample collections where the controls had definite open
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angles (N= 3,458 PACG cases and N=3,831 controls, per-allele
OR=1.30, P=7.4561029; Figure 1 and Table 2).
We also performed conditional analyses of the ABCC5 variant
with the previously implicated PACG loci [6] and observed no
change in either the odds ratio or p-values of the association.
(Table S3).
Expression of ABCC5 in eye tissues
RT-PCR analysis on human ocular tissues demonstrated that
ABCC5 is expressed in anterior segment structures relevant to
PACG such as the iris, ciliary body, and lens (Figure S3).
Additionally, Abcc5 message and protein were confirmed in mouse
ocular tissues using in situ hybridization and immunohistochem-
istry (Figure S4, S5).
Discussion
In this study, a GWAS of ACD in Singaporean Indians and
Malays and Chinese from Beijing China found rs1401999 within
ABCC5 to contribute to the normal variation of ACD, a
quantitative trait relevant to PACG. Interestingly, none of the
previously identified PACG-associated genetic variants [6] were
significantly associated with ACD [18]. We also demonstrated the
association of rs1401999 with PACG using case-control cohorts
from multiple populations across Asia. Importantly this association
surpassed GWAS significance when the analysis was confined to
control pre-selected to have open angles.
ABCC5, also known as multidrug resistance protein 5 (MRP5),
has been shown to participate in tissue defense and cellular signal
transduction through efflux of anticancer drugs, toxicants and a
second messenger cGMP [19]. [20], [21]. It is expressed in
most human tissues, including the cornea [22], retinal pigment
epithelium and retina of the eye [23]. We also noted ABCC5
expression in ocular structures relevant to PACG such as the iris,
ciliary body, and lens. However, its exact role in the context of
PACG is not yet known. The significant association between
ABCC5 rs1401999 with a shallower ACD argues favorably for a
role in eye growth, particularly that of the anterior segment.
Intriguingly, a study in zebrafish suggested that Abcc5 may play an
active role in eye development through the regulation of
intracellular cGMP levels. Zebrafish Abcc5, which shares 73%
amino acid sequence identity with human ABCC5, is highly
expressed in the lens of the developing eye [24]. Notably, the
blockage of endogenous ABCC5 activity by its dominant-negative
was shown to retard development, producing smaller eyes as well
as overall reduction of body length and pigmentation of embryos
[24]. Abcc5 knockout mice have been generated but an evaluation
of their eyes was not reported [25]. A developmental role for
ABCC5 in mammalian eyes therefore remains to be defined and
will require further detailed studies in model organisms.
In addition, the linkage disequilibrium (LD) block that includes
rs1401999 and ABCC5, also includes the presenilin-associated
rhomboid-like (PARL) gene, 5-hydroxytryptamine receptor 3D
(HTR3D) gene and the 5-hydroxytryptamine receptor 3C
(HTR3C) gene (Figure S6). It is thus possible that rs1401999
might simply be in LD with an as yet unidentified causal variant,
and it remains unclear whether the causal alleles or group of alleles
influence ABCC5 or any of the neighboring genes to influence
ACD. However, the clear expression within ocular tissues and a
possible role in eye development make ABCC5 a rather attractive
candidate gene for ACD. Indeed, re-sequencing of the region will
be necessary to identify novel potentially functional polymor-
phisms related to PACG pathogenesis.
The prevalence of the pre-cursor stage of PACG, namely
narrow angles, is about 10% in many Asian populations [3], [17].
Given the association between angle closure and shallow ACD
[11] it is therefore appropriate to remove the ‘at-risk individuals’
from the control population in order to assess the true relationship
between ACD QTLs and PACG. Unsurprisingly, the evidence of
association between rs1401999 and PACG was augmented when
we only included sample collections where the controls had
definite open angles. Similar observations have also been seen with
very recent studies on Alzheimer’s disease, where the inclusion of
general population-based controls resulted in significant underes-
timation of the odds ratio conferred by the disease-associated SNP
compared to when properly matched, risk-free controls were
applied, [26]. [27], [28]. We caution that the modest statistical
evidence reported here for rs1401999, when examined in a total of
4,276 PACG cases and 18,801 controls, is at least 5 orders of
magnitude below that of the three PACG-associated variants from
our recent GWAS study [6]. Clinical studies have shown that
ACD is only a modest determinant of angle width [29]. Therefore,
this may explain why an ACD controlling gene such as ABCC5
would only confer a relatively small effect on PACG disease itself.
Incidentally, the proportion of PACG risk explained by ABCC5
rs1401999 is 0.35% (95% confidence interval = 0.01 to 1.2%). Our
study highlights the fact that even larger sample sizes may be
necessary to dissect and conclusively identify the possible modifiers
of genetic risk conferred by variants of modest effects, particularly
when they exert their action on disease pathogenesis via
endophenotypes. The following observations can also be drawn
from this study. It is important that all sample collections are
included and assessed transparently especially when drawn from
diverse populations. Secondly, despite the broad-based success in
the use of large numbers of unselected, population-based controls
in genetic studies [30], [31], [32], [33], [34], [35] the deployment
of controls with proper clinical phenotyping and documentation
will often assist in more definitive identification of susceptibility
genes. A comprehensive examination of all variation around
ABCC5 using targeted deep re-sequencing is now necessary to
parse the true association signal in an effort to more completely
understand the role of this gene in ACD and PACG.
In summary our study identified a common genetic variant
within ABCC5 as being significantly associated with ACD, which
was also associated with a modest risk of PACG. Our findings are
Author Summary
The anterior chamber is the space within the eye which is
bound by the cornea, and the anterior surfaces of the iris
and lens. Anterior chamber depth (ACD) is the distance
measured along the eye’s optical axis, from the cornea to
the lens surface. ACD is an important risk factor for primary
angle closure glaucoma (PACG), a major cause of irrevers-
ible blindness worldwide, and in particular, individuals of
Asian ethnicity. In order to identify the genes that underlie
PACG susceptibility, we conducted a two-staged study. We
first conducted a large scale genetic study on a total of
5,308 population-based individuals of Asian descent to
identify the genetic variants that influence ACD. This was
followed by testing for associations between the identified
genetic variant and PACG in another independent collec-
tion of 4,276 PACG cases and 18,801 controls. We found
that a genetic variant within ABCC5 was associated with an
increased risk of having PACG. Our findings suggest that
the increase in PACG risk could in part be mediated by
genetic sequence variants that influence the anterior
chamber dimensions of the eye.
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largely in keeping with the anatomical risk factors of individual
susceptibility to PACG in the eye, whereby shallower ACD is a
cardinal clinical and pathogenic feature, predisposing the eye to
more ‘crowded’ anterior segment and thus increasing the risk of
PACG. Our study provides further clues to genetic mechanisms
underlying this major global cause of blindness.
Materials and Methods
Sample collections analyzed for Anterior Chamber Depth
Anterior chamber depth (ACD) measurements were derived
from three population based samples: the Singapore Malay Eye
Study (SiMES), the Singapore Indian Eye Study (SINDI) and the
Beijing Eye Study (BES).
SiMES. The Singapore Malay Eye Study (SiMES) was a
population-based, cross-sectional study of 3280 Malay adults aged
40 to 79 years. Details of the SiMES design, sampling plan, and
methods have been reported elsewhere [36]. In brief, an age-
stratified random sampling of all Malay adults, aged 40 to 80
years, residing in 15 residential districts in the south- western part
of Singapore was drawn from the computer-generated random list
of 16,069 Malay names provided by the Ministry of Home Affairs.
A total of 1400 names from each decade of age (40–49, 50–59, 60–
69, and 70–79 years), or 5600 names, were selected. Of these,
4168 individuals (74.4%) were determined to be eligible to
participate. A person was considered ineligible if he or she had
moved from the residential address, had not lived there in the past
6 months, was deceased, or was terminally ill. Of the 4168 eligible
individuals, 3280 participants (78.7%) took part in the study. The
study was conducted from August, 2004 to June, 2006.
SINDI. As with SiMES, the Singapore Indian Eye Study
(SINDI) was a population-based, cross-sectional epidemiological
study, but of ethnic Indian adults aged between 40 and 80+ years
residing in Singapore. The Ministry of Home Affairs provided an
initial computer-generated list of Indian names derived from a
simple random sampling of all ethnic Indian adults aged 40–80+
years of age residing in 15 residential districts in south-western
Singapore. From this list, a final sampling frame of 6,350 ethnic
Indian residents was derived using an age-stratified random
sampling strategy similar to SiMES. SINDI was conducted from
March, 2007 to December, 2009 and recruited 3,400 (75%
response rate) participants [37].
BES. The Beijing Eye Study was a population-based, cross-
sectional study of Chinese adults aged 40+ years and residing in 4
communities in the urban district of Haidian in the North of
Central Beijing and in 3 communities in the village area of Yufa of
the Daxing District south of Beijing [38]. At the time of the first
survey in the year 2001, the 7 communities had a total population
of 5324 individuals aged 40 years or older and eligible to take part
in the study. In total, 4439 individuals participated in the eye
examination (83.4% response rate). In the year 2006, when blood
samples were taken, the study was repeated by re-inviting all
participants from the survey from 2001 to be re-examined with
3251 subjects participating (73.3% response
rate).
Measurement and analysis of Anterior Chamber Depth
(ACD). ACD was measured using the IOLMaster (Carl Zeiss
Meditec, Dublin, CA). Five readings were obtained and the
average computed. The signal-to-noise ratio for all readings were
.2.0, which indicate that a clear signal was obtained when
performing the measurement. All the readings were within
0.05 mm of the one with the highest signal-to-noise ratio.
The ACD measurements used in the GWAS excluded any
measurements from any eye which were pseudophakic or
aphakic. For collections with data from two phakic eyes (SiMES,
SINDI), individuals were excluded whose ACD measurements
between the two eyes differed more than 0.2 mm (which
represented the top ,20th percentile of symmetrical data) which
gave a good correlation between the left and the right eye
(r2.0.95 in both SiMES and SINDI). However, given that BES
only had measurements for the right eye; final meta-analysis
used ACD measurements taken from the right eye in all three
cohorts.
PACG case-control cohorts. The subjects for the PACG
case-control study were compiled from 11 independent sample
collections enrolled from 8 different countries; and have been
described previously [6]. Furthermore, we have included an
additional PACG case-control collection from Japan (136 cases
and 419 controls) as well as an additional 436 PACG cases from the
Beijing site. The PACG cases and controls were defined using the
same criteria as described previously [6].
Selection of controls without angle closure. These controls were
selected from within the population-based samples based on
robust clinical criteria. A control was defined as having an
Table 1. Quantitative trait analysis between ABCC5 rs1401999 and anterior chamber depth in SIMES, SINDI, and BES.
Collection N Minor Allele b SE Pgc MAF
SIMES 1752 C 20.056 0.0149 1.7661024 0.15
SINDI 1860 C 20.041 0.0115 3.9761024 0.41
BES1 872 C 20.026 0.0196 0.19 0.16
BES2 824 C 20.058 0.0227 0.011 0.16
All BES 1696 C 20.040 0.0148 0.0075 0.16
Meta-analysis* 5308 C 20.045 0.00775 8.1761029
SIMES: Singapore Malay Eye Study (typed with Illumina 610K GWAS chip).
SINDI: Singapore Indian Eye Study (typed with Illumina 610K GWAS chip).
BES1: Beijing Eye Study typed with Illumina 610K GWAS chip.
BES2: Beijing Eye Study typed with direct sequencing.
b: Per-allele effect size of ABCC5 rs1401999 on anterior chamber depth.
SE: Standard error for b.
Pgc: Genomic control corrected P-value.
MAF: Minor allele frequency.
*: I2-index for heterogeneity = 0%.
doi:10.1371/journal.pgen.1004089.t001
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intraocular pressure (IOP),21 mmHg with open angles (on
gonioscopy) in all quadrants, healthy optic nerves and normal
visual fields, and no previous intraocular surgery.
Ethics. All involved studies were conducted in accordance
with the principles of the Declaration of Helsinki. Study
procedures and protocols were approved by the Institutional
Review Board of each local institution involved in the study, and
all study participants provided written informed consent at the
recruitment into the studies.
Genotyping
ACD GWAS. Genotyping in the following sample collections
(SIMES, N=1752; SINDI, N= 1860; BES1, N=872) was
performed using the Illumina 610K Quad BeadChips following
manufacturer instructions after genomic DNA were extracted
from participants using standard laboratory techniques. Genotyp-
ing of SNP ABCC5 rs1401999 in an additional 824 participants
from the Beijing Eye Study (termed BES2) was performed using
direct capillary sequencing.
PACG sample collections. Genome-wide genotyping was per-
formed for a total of 1,854 PACG cases and 9,608 controls using
Illumina SNP-arrays. A further 1,917 PACG cases and up to 8,943
controls were genotyped using the Sequenom MassArray and
Taqman real-time PCR method (Table S2).
Statistical analysis. Genome-wide per-cohort and meta-
analysis of ACD for all three sample collections was performed
using standard procedures as previously described [39], [40], [41].
A selection of stringent QC filters were applied to remove poorly
performing SNPs and samples using tools implemented in PLINK
version 1.7 [42]. The QC criteria were as follows: SNPs that had
.5% of missing genotypes, gross departure from Hardy-Weinberg
equilibrium (test for HWE showing P,1026) or were of minor
allele frequency below 1% were excluded from downstream
analysis. For sample QC, samples with an overall genotyping call
rate of ,95% were excluded from analysis. Principal component
(PC) analysis was undertaken to account for spurious associations
resulting from ancestral differences of individual SNPs. PC plots
were performed using the R statistical program package (www.r-
project.org/).
For the GWAS on ACD, linear regression was performed to test
for association between SNP genotypes and ACD as implemented
by PLINK (version 1.06). Individual SNP genotypes were coded
according to the number of copies of the minor allele present: 0 for
the wild-type genotype, 1 for heterozygotes, and 2 for homozygote
variants. A trend test using linear regression was used for primary
association testing between genotypes and ACD as a quantitative
trait, adjusting for age, gender, and the significant axes of genetic
stratification. Meta-analysis across SiMES, SINDI and BES was
performed using the inverse-variance, fixed effects model in order
to obtain a combined point estimate of the overall effect size (b)
coefficients and its corresponding standard error (SE). Inter-
cohort heterogeneity was assessed with the Cochran’s Q statistic
and its accompanying I2 index. Quantile-quantile (QQ) and
Manhattan plots were created using the software R (www.r-
project.org). After sample and genotyping QC, a total of 1752,
1860, 872 individuals with complete data for ACD measure-
ments, age and gender were available for SiMES, SINDI and
BES individual GWAS. The overall genomic inflation factor for
the meta-analysis of the three sample collections was minimal
(lgc = 1.036; see Figure S1). We considered P,561028 as
genome-wide significant, and the previously used threshold for
genome-wide significance (P,561027) as ‘highly suggestive
evidence of association [43].
Descriptions of the GWAS datasets used in the current study,
principal component analysis, and adjustment for population
stratification have been described elsewhere (Table S4) [39], [40],
[41].
For the PACG sample collections, the analysis was performed as
previously described, with associations between ABCC5 rs1401999
and PACG modeled using logistic regression.
Power calculations. A power calculation was conducted for
bringing forward genome-wide significant SNPs from the ACD
quantitative trait analysis to the PACG case control analysis (for
4,276 cases and 18,801 controls) (Supplementary Table S5). The
power calculation is consistent with the findings we report in the
current manuscript.
Expression analysis
RT-PCR in human ocular tissues. Expression of ABCC5 was
assessed by semi quantitative reverse transcription PCR (RT-PCR)
using ABCC5 specific primers (forward 59- ATTGG-
CATTGTGGGGCGGAC -39 and reverse 59- CCTCTCC-
AGGGCATCCCAAATC -39) on total RNA extracted from a
variety of ocular tissues (anterior sclera, cornea, iris, ciliary body,
trabecular meshwork, lens, lens capsule, retina and retinal pigment
epithelium, optic nerve head and optic nerve) with TRIzol
Reagent (Invitrogen, Carlsbad, California) in accordance with the
manufacturer’s protocol. First-strand cDNA synthesis was per-
formed with SuperScript First-Strand Synthesis System for RT-
PCR (Invitrogen, Carlsbad, California). Semi quantitative RT-
PCR was performed according to manufacturer’s protocol, with
the SYBR Green Master Mix (Invitrogen, Carlsbad, California)
using the above ABCC5 primers. The resulting PCR products were
Figure 1. Association analysis between ABCC5 rs1401999 and
susceptibility to primary angle closure glaucoma (PACG). The
PACG sample collections have been described elsewhere [6]. The
vertical line represents a per-allele odds ratio of 1.00. The oblongs
represent point estimates (referring to the per-allele odds ratio), with
the height of the oblongs inversely proportional to the standard error
of the point estimates. Horizontal lines indicate the 95% confidence
interval for each point estimate. Meta-analyses of samples are reflected
by blue diamonds. The width of the diamonds indicates their 95%
confidence intervals. All point estimates in Stage 1 have been adjusted
for the top axes of genetic stratification using logistic regression.
doi:10.1371/journal.pgen.1004089.g001
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separated on a 2% agarose gel and visualized by ethidium bromide
staining. The ubiquitously expressed beta-actin (ACTB) gene was
amplified using specific primers (forward 59- CCAACCGCGA-
GAAGATGA -39 and reverse 59- CCAGAGGCGTACAGGGA-
TAG-39) and used as amplification and normalizing control. The
ABCC5 primer sequences were derived from NCBI Reference
Sequence: NM_005688.2.
In situ hybridization. In situ hybridization was performed on 12-
mm-thick 4% paraformaldehyde (PFA) fixed ocular sections using
Dig-labeled riboprobe. Digoxigenin-labeled (DIG-labeled) ribop-
robes for mouse Abcc5 were transcribed from cDNA clones (Open
Biosystems clone ID: 6839816). For anti-sense probe generation,
the plasmid was digested with EcoRI and transcribed with T3
polymerase. While for the sense probe Not1 and T7 were used.
For this procedure, C57BL/6J or A/J mice were perfused
transcardially with 4% PFA in Phosphate buffered saline (PBS).
Eyes were postfixed in 4% PFA overnight, cryoprotected in 30%
sucrose, and embedded in Optimal Cutting Temperature embed-
ding medium (Tissue-Tek O.C.T. Compound, Sakura Finetek
U.S.A., Inc., Torrance, CA). Frozen sections were air dried
(10 min), postfixed (4% PFA; 10 min) and acetylated with 0.25%
acetic anhydride in 0.1 M triethanolamine (TEA). Intercalated
washes were done with PBS and after the last wash the sections
were incubated overnight at 65uC with hybridization solution
[50% formamide, 16 Hybe solution (Sigma-Aldrich, St. Louis,
MO), 1 mg/ml yeast RNA] containing 1 mg/ml Dig-labeled
riboprobes. After hybridization, slides were washed with 0.26SSC
at 72uC for 1 h, and endogenous peroxidases were quenched with
a solution of 0.1% sodium azide and for 10 min. Bound probes
were detected with an POD-conjugated anti-Dig antibody. The
Table 2. Association analysis between ABCC5 rs1401999 and primary angle closure glaucoma in all chip-typed sample collections
(top panel), de-novo genotyped sample collections (middle panel), and PACG cases and clinically certified controls with open
angles (bottom panel).
Stage 1 (Chip-typed sample collections)
Collection MAF case MAF control OR P
Singapore 0.135 0.109 1.27 0.017
Hong Kong 0.147 0.132 1.16 0.38
India 0.493 0.408 1.29 2.8361025
Malaysia* 0.175 0.150 1.21 0.38
Vietnam 0.143 0.121 1.21 0.25
Meta-analysis (Stage 1) 1.23 9.8461025 (I2 = 0.0%)
Stage 2 (De-novo genotyped sample collections)
Collection MAF case MAF control OR P
China (Beijing){ 0.173 0.139 1.29 0.00045
Singapore 0.120 0.143 0.82 0.17
China (Shantou) 0.131 0.150 0.85 0.31
Japan 0.136 0.113 1.23 0.32
India 0.477 0.442 1.15 0.41
Saudi Arabia 0.432 0.484 0.83 0.16
United Kingdom 0.412 0.453 0.85 0.22
Meta-analysis (Stage 2) 1.06 0.23 (I2 = 67.5%)
Meta-analysis (Stages 1 and 2) 1.13 0.00046 (I2 = 60.6%)
ABCC5 rs1401999 genotyped in PACG cases and clinically certified open-angled controls only
Collection MAF case MAF control OR P
Singapore 0.132 0.109 1.24 0.026
Hong Kong 0.159 0.103 1.64 0.012
India 0.489 0.429 1.28 0.0047
Beijing{ 0.173 0.139 1.29 0.00045
Japan 0.136 0.113 1.23 0.32
Meta-analysis 1.30 7.4561029 (I2 = 0.0%)
MAF case: Minor allele frequency in PACG cases.
MAF control: Minor allele frequency in controls.
OR: Odds ratio.
P: P-value for association with PACG.
I2: I-squared index for between-collection heterogeneity.
* Results here are presented based on raw minor allele frequency counts without further adjustment.
{PACG patients were recruited from the Beijing Tongren Hospital and controls were recruited from the Handan Eye Study (HES), a population-based study of eye disease
in rural Chinese aged 30 years and over.
doi:10.1371/journal.pgen.1004089.t002
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detection of hybridized mRNA in sections was performed using
the Cy-3 Tyramide Signal Amplification System (PerkinElmer,
Waltham, MA).
Immunohistochemistry. Enucleated eyes from A/J mice were
embedded in Optimal Cutting Temperature embedding medium
(Tissue-Tek O.C.T. Compound, Sakura Finetek U.S.A., Inc.,
Torrance, CA). The eyes were cryo-sectioned (14 mm) and
transferred to glass slides. Cryosections were air dried for
10 min at room temperature, fixed for 10 min in 4% paraformal-
dehyde, followed by two washes (5 min each) in phosphate
buffered saline (PBS). Sections were blocked 30 min at room
temperature with 10% normal donkey serum. Primary antibodies
were applied for 1 hr at room temperature using polyclonal goat
anti-ABCC5 antibody (diluted 1:300; Catalog No. sc-5781,
Santacruz Biotechnology Inc., Santacruz, CA). Primary antibody
was removed by three washes (5 min each) in PBS and the sections
were treated for 1 hr at room temperature with AlexaFluor
conjugated secondary antibodies (1:200 dilution, Jackson-Immu-
noResearch, West Grove, PA) diluted in 1% normal donkey serum
and 10 mg/mL BSA in PBS. After three washes in PBS, the sections
were mounted (Fluormount, Sigma-Aldrich, St. Louis, MO) and
viewed by fluorescence microscopy. All photomicrographs were
taken with identical camera settings. For peptide blocking experi-
ments, the antibody was preincubated with 106concentration of the
blocking peptide (sc-5781P, Santacruz Biotechnology Inc., Santa-
cruz, CA), incubated for 2 h at room temperature prior to treating it
with the sections.
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asense probe (S) control is shown in the right panel. Scale bar,
50 mm.
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Figure S5 Immunohistochemical localization of ABCC5 in
ocular tissues: Cryosections of whole eyes from wild-type A/J
mice were imaged using fluorescence microscopy. ABCC5 is
present in: A) iris (I), cornea (C), B) ciliary body (CB), and C)
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